BackSatsuma Pharmaceuticals Overview

Satsuma Pharmaceuticals Net Income

Profitability analysis for STSA.

Quarterly Net Income

-$9.82M
↑ 36.6% YoY

As of Mar 2023

Annual Net Income (TTM)

-$63.33M
↓ 12.74% YoY

Trailing 12 months ending Mar 2023

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin